Cigna Group (CI) vs Illumina (ILMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Illumina (ILMN) has outperformed Cigna Group (CI) over the past year, gaining 177.0% versus a loss of 9.3%. Over five years, CI leads with a +35.1% price change compared with -32.9% for ILMN. Cigna Group is the larger company by market cap ($73.59 billion vs $40.43 billion), about 1.8 times the size.
On valuation, Cigna Group trades at a lower forward P/E (8.3x vs 43.8x for Illumina). Cigna Group pays a dividend yielding 2.20%, while Illumina does not currently pay one. Illumina converts more of its revenue into profit, with a net margin of 19.6% versus 2.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CI | ILMN |
|---|---|---|
| Share price | $278.51 | $267.76 |
| Market cap | $73.59B | $40.43B |
| 1-day change | +1.51% | -2.11% |
| YTD return | +1.19% | +104.15% |
| 1-year return | -9.32% | +176.95% |
| 5-year return | +35.07% | -32.85% |
| P/E ratio (TTM) | 11.51 | 49.96 |
| Forward P/E | 8.31 | 43.83 |
| EPS (TTM) | $24.19 | $5.36 |
| Dividend yield | 2.20% | 0.00% |
| Annual dividend | $6.14 | $0.00 |
| Revenue (latest FY) | $274.90B | $4.34B |
| Revenue growth (YoY) | +11.24% | -0.66% |
| Net income (latest FY) | $5.96B | $850.00M |
| Gross margin | 21.79% | 66.08% |
| Operating margin | 3.35% | 18.58% |
| Net margin | 2.17% | 19.57% |
| 52-week high | $312.18 | $309.35 |
| 52-week low | $239.51 | $88.00 |
| Distance from 52-week high | -10.79% | -13.44% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +22.90% | -16.40% |
| Average volume | 1.67M | 2.66M |
| Shares outstanding | 264.24M | 151.00M |
| Employees | 65,669 | 8,600 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ILMN has outperformed CI by 186.3 percentage points over the past year.
- Illumina trades at a higher earnings multiple (50.0x vs 11.5x trailing P/E).
- Cigna Group offers a meaningfully higher dividend yield (2.20% vs 0.00%).
- Illumina is more profitable, keeping 19.6 cents of every revenue dollar as net income versus 2.2 cents for Cigna Group.
- Cigna Group grew revenue faster in its latest fiscal year (+11.24% vs -0.66%).
About Cigna Group
CI stock →The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
Health Care · Medical Specialities · 65,669 employees
About Illumina
ILMN stock →Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Health Care · Medical Specialities · 8,600 employees
CI vs ILMN FAQ
Which is bigger, Cigna Group or Illumina?
Cigna Group (CI) is larger, with a market capitalization of $73.59B compared with $40.43B for Illumina (ILMN).
Which stock has performed better over the past year, CI or ILMN?
ILMN returned +176.95% over the past 12 months, compared with -9.32% for CI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CI or ILMN?
CI has the lower trailing P/E at 11.5, versus 50.0 for ILMN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cigna Group or Illumina?
Cigna Group pays a dividend yielding 2.20%, while Illumina does not currently pay a regular dividend.
Are Cigna Group and Illumina in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.